Dr David Woolf

Consultant Clinical Oncologist

BMedSci, MBChB, MRCP (UK), FRCR, MSc, MD (Res)

Professional Membership

  • General Medical Council
  • Royal College of Radiologists
  • Medical Protection Society
  • American Society for Radiation Oncology
  • European Society for Radiotherapy & Oncology
  • American Society of Clinical Oncology
  • European Society for Medical Oncology
  • British Medical Association
  • Faculty of Medical Leadership and Management

Clinical Interests

  • Breast cancer treatments
  • Lung cancer treatments
  • Radiotherapy
  • Chemotherapy
  • Hormone therapy (endocrine therapy)
  • Targeted therapy
  • Stereotactic Ablative Radiotherapy (SABR)
  • Intraoperative Radiotherapy (IORT)

Personal profile

Dr David Woolf is a graduate of the University of Birmingham. Core medical and clinical oncology training was undertaken in London at University College Hospital, The Royal Free and St Bartholomew’s. Dr Woolf later completed a Masters in Oncology at the Institute of Cancer Research and a Doctorate of Medicine at Mount Vernon Cancer Centre.

Dr Woolf has a particular interest in the development of high quality health care, participating as a member of the Keogh Quality of Care Review Inspections Panel and as Clinical Expert in Care Quality Commission (CQC) inspections.

During his career Dr Woolf has had over 20 publications in peer reviewed journals, published book chapters as well as over 40 oral and poster presentations to national and international conferences. These include multiple publications and presentations in the field of breast and lung cancer.

Dr Woolf also runs regular teaching sessions for junior doctors. He examines on The Christie FRCR examination course and has worked extensively with the Royal College of Radiologists to enhance training for clinical oncologists.

Dr Woolf plans and delivers radiotherapy at The Christie to patients with breast and lung cancers and also gives Stereotactic Ablative Radiotherapy (SABR) for lung cancers and oligometastases (cancers that have spread to the lungs). In addition he gives hormone therapy (endocrine therapy), chemotherapy and targeted drugs.

Year qualified: